11/4/25
(Reuters) -Kimberly-Clark will buy Band-Aid maker Kenvue for more than $40 billion in a historic deal that comes as the smaller company faces lawsuits over painkiller Tylenol, White House attacks and choppy demand.
Kimberly-Clark shares dropped sharply after the announcement, while Kenvue jumped 17.5%. The company is paying a hefty 46% premium for the former Johnson & Johnson unit that has had a turbulent year. Kenvue ousted its CEO in July and has been under fire from the White House over unproven claims that Tylenol use during pregnancy can cause autism in children.
11/4/25
(Reuters) -Kimberly-Clark will buy Band-Aid maker Kenvue for more than $40 billion in a historic deal that comes as the smaller company faces lawsuits over painkiller Tylenol, White House attacks and choppy demand.
Kimberly-Clark shares dropped sharply after the announcement, while Kenvue jumped 17.5%. The company is paying a hefty 46% premium for the former Johnson & Johnson unit that has had a turbulent year. Kenvue ousted its CEO in July and has been under fire from the White House over unproven claims that Tylenol use during pregnancy can cause autism in children.
投資の参考になりましたか？